Symmetry Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,293
| Closed | -$300K | – | 141 |
|
|
2024
Q2 | $300K | Hold |
1,293
| – | – | 0.02% | 405 |
|
|
2024
Q1 | $279K | Hold |
1,293
| – | – | 0.02% | 438 |
|
|
2023
Q4 | $337K | Hold |
1,293
| – | – | 0.02% | 367 |
|
|
2023
Q3 | $332K | Sell |
1,293
-314
| -20% | -$80.6K | 0.02% | 410 |
|
|
2023
Q2 | $458K | Sell |
1,607
-671
| -29% | -$191K | 0.02% | 363 |
|
|
2023
Q1 | $633K | Hold |
2,278
| – | – | 0.03% | 268 |
|
|
2022
Q4 | $631K | Hold |
2,278
| – | – | 0.04% | 267 |
|
|
2022
Q3 | $608K | Buy |
2,278
+674
| +42% | +$180K | 0.04% | 257 |
|
|
2022
Q2 | $327K | Buy |
+1,604
| New | +$327K | 0.02% | 439 |
|
|
2021
Q4 | – | Sell |
-2,845
| Closed | -$798K | – | 606 |
|
|
2021
Q3 | $798K | Sell |
2,845
-371
| -12% | -$104K | 0.05% | 276 |
|
|
2021
Q2 | $1.11M | Hold |
3,216
| – | – | 0.07% | 203 |
|
|
2021
Q1 | $900K | Sell |
3,216
-336
| -9% | -$94K | 0.06% | 225 |
|
|
2020
Q4 | $870K | Sell |
3,552
-2,082
| -37% | -$510K | 0.07% | 216 |
|
|
2020
Q3 | $1.6M | Buy |
5,634
+2,944
| +109% | +$835K | 0.14% | 99 |
|
|
2020
Q2 | $720K | Buy |
+2,690
| New | +$720K | 0.09% | 94 |
|
|
2019
Q3 | – | Sell |
-1,723
| Closed | -$403K | – | 338 |
|
|
2019
Q2 | $403K | Sell |
1,723
-648
| -27% | -$152K | 0.08% | 196 |
|
|
2019
Q1 | $560K | Buy |
2,371
+617
| +35% | +$146K | 0.1% | 137 |
|
|
2018
Q4 | $528K | Buy |
+1,754
| New | +$528K | 0.13% | 101 |
|